BWX Technologies (NYSE:BWXT) experienced a notable decline on Tuesday, with shares falling 3.4% to $170.53 during regular trading hours. This drop occurred even as the broader S&P 500 index advanced 0.5%, highlighting a company-specific headwind. The selloff comes despite a fresh bullish call from JPMorgan Chase & Co. (NYSE:JPM), which initiated coverage with an Overweight rating and a price target of $230, implying roughly 35% upside from current levels.
JPMorgan's Positive Outlook
JPMorgan analyst Tomohiko Sano initiated coverage on Monday, describing BWX Technologies as a "leader in nuclear manufacturing and materials handling." Sano emphasized the company's strong government connections, nuclear licenses, and expertise in producing heavy components. The $230 price target reflects confidence in the firm's strategic position within the nuclear sector, which has been gaining attention amid global energy transitions.
Earnings Expectations and Market Sentiment
BWXT is set to release its second-quarter earnings after the market close on Monday, with a conference call scheduled for 5 p.m. EDT. Preliminary consensus estimates call for revenue of $903.77 million and earnings per share (EPS) of $1.04. This would represent an 18.3% year-over-year revenue increase, but EPS growth of only about 2%, a modest figure that has tempered some investor enthusiasm.
The quarterly EPS projection is down 4.6% from April's estimates. However, the full-year 2026 outlook has improved, rising 2.2% to $4.71. This implies a significant acceleration in the second half of the year, with consensus EPS of approximately $2.55, representing a 22.6% increase compared to the same period last year. The bridge between the modest Q2 and robust H2 expectations is a key focus for analysts.
Operational Leverage and Growth Drivers
The company's first-quarter results showed strong operational leverage. Revenue surged 26% to $860.2 million, while non-GAAP EPS climbed 22% to $1.12. This growth was primarily driven by Commercial Operations, which posted a 121% revenue increase and a 162% jump in adjusted EBITDA. In contrast, Government Operations saw only a 1% EBITDA rise, indicating a divergence in performance across segments.
At the end of March, BWXT's backlog stood at $8.65 billion, a 77% year-over-year increase. Of this, $6.93 billion was attributed to government contracts, underscoring the company's reliance on federal programs. The recent acquisition of Precision Components Group (PCG) on July 6 adds over 500,000 square feet of capacity and more than 450 employees, though its impact was not included in the earlier 2026 outlook. John MacQuarrie, President of Commercial Operations, noted that the increased capacity will support "reactor life-extension programs, new build activity."
Valuation and Sector Context
Tuesday's share price corresponds to roughly 36 times projected 2026 consensus EPS, a significant drop from the April peak of about 51 times that forecast. This valuation compression reflects market caution ahead of the earnings report. Broader nuclear-related stocks also traded lower: Cameco Corp. (NYSE:CCJ) fell 2.5%, Constellation Energy Corp. (NASDAQ:CEG) declined 2.1%, and Oklo Inc. (NYSE:OKLO) dropped 4.1%.
Key Risks and Outlook
Execution remains the primary concern for BWXT. The timing of contracts, federal funding approvals, regulatory clearances, labor availability, and the integration of PCG could all affect the anticipated second-half ramp-up. Monday's earnings report must surpass a reduced quarterly benchmark, with investors seeking evidence that revenue growth will translate into accelerated earnings by year-end. The market's focus is squarely on the company's ability to deliver on its H2 potential.
